0004-1963

Arhiv za farmaciju

Centre for Evaluation in Education and Science

View prefix report (10.5937)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 131 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact131 DOIs
2

Attach ORCID iDs across 113 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact113 DOIs
3

Add license metadata to 76 records

License metadata tells indexers and readers how each article may be reused.

Low impact76 DOIs

DOIs for this ISSN

Showing the top 5 of 305 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Investigation of omeprazole stability in oral suspensions fo… (10.5937/arhfarm1701014m)
Abstract References ORCID License
77.82 5
2 Providing clinical evidence under the MDR 2017/745: New chal… (10.5937/arhfarm1901039i)
Abstract ORCID License
67.73 7
3 Application of yarrow (Achillea millefolium L.) in ethnomedi… (10.5937/arhfarm1905367m)
Abstract ORCID
57.31 13
4 Pharmaceutical-technological aspects of therapeutic systems… (10.5937/arhfarm1605217d)
Abstract References ORCID License
47.71 2
5 How to diagnose and treat patients with inflammatory bowel d… (10.5937/arhfarm1702091s)
Abstract ORCID License
45.15 3
6 Biocompatible non-covalent complexes of chitosan and differe… (10.5937/arhfarm2004173q)
Abstract
33.56 21
7 Pseudoephedrine: A potential risk of doping in sport (10.5937/arhfarm1605239a)
Abstract References ORCID License
30.10 1
8 Novel delivery systems with nonsteroidal anti-inflammatory d… (10.5937/arhfarm1606267c)
Abstract References ORCID License
30.10 1
9 Herbal medicinal products in the treatment of pain as a symp… (10.5937/arhfarm1606284m)
Abstract References ORCID License
30.10 1
10 Nutrition and dietary supplements in the prevention of osteo… (10.5937/arhfarm1606293v)
Abstract References ORCID License
30.10 1
11 Matrix metalloproteinases-9 and tissue inhibitor of matrix m… (10.5937/arhfarm1701001i)
Abstract References ORCID License
30.10 1
12 Prevention and treatment of hypertension in everyday pharmac… (10.5937/arhfarm1701041s)
Abstract References ORCID License
30.10 1
13 In silico methodology in toxicology: Software for toxicity p… (10.5937/arhfarm1901028j)
Abstract License
30.10 3
14 Investigation of the influence of critical process parameter… (10.5937/arhfarm2001034a)
Abstract ORCID
30.10 3
15 Relevance and evaluation of the benchmark dose in toxicology (10.5937/arhfarm2003130b)
Abstract
27.85 12
16 Endocrine-disrupting activity of mancozeb (10.5937/arhfarm71-34359)
ORCID
26.03 10
17 Effects of anti-age cosmetic products: Claims substantiation (10.5937/arhfarm1703209d)
Abstract License
23.86 2
18 Preservatives, colorants and UV filters in cosmetic products… (10.5937/arhfarm1805934l)
Abstract ORCID
23.86 2
19 Why is there a need for cosmetics safety risk assessment? (10.5937/arhfarm1805971d)
Abstract ORCID
23.86 2
20 Organic and natural cosmetic products : How safe are they? (10.5937/arhfarm1805990v)
Abstract ORCID
23.86 2
21 Childhood vaccination in the twenty-first century: Parental… (10.5937/arhfarm1906452j)
Abstract ORCID
23.86 2
22 SUR2A: How to exploit this protein to treat ischaemic heart… (10.5937/arhfarm2001001j)
Abstract ORCID
23.86 2
23 Ethnopharmacological application of chamomile (Matricaria ch… (10.5937/arhfarm2004238m)
Abstract
23.86 8
24 Endocrine disruption by PFAS: A major concern associated wit… (10.5937/arhfarm71-34197)
ORCID
23.86 8
25 Herbal medicinal products in the treatment of depression (10.5937/arhfarm1705302p)
Abstract ORCID License
22.58 1
26 Characteristics of vaginal delivery systems (10.5937/arhfarm1706360f)
Abstract ORCID License
22.58 1
27 Safety of cosmetic products in the light of European legisla… (10.5937/arhfarm1805911s)
Abstract
21.13 6
28 Engineering cocrystals of Paliperidone with enhanced solubil… (10.5937/arhfarm71-32997)
ORCID
21.13 6
29 Herbal and traditional Herbal Medicinal Products, EU Herbal… (10.5937/arhfarm1904221p)
Abstract
19.45 5
30 Endocrine disrupting mechanisms and effects of pesticides (10.5937/arhfarm71-34291)
ORCID
19.45 5
31 KATP channels and cardioprotection (10.5937/arhfarm74-51604)
ORCID
19.45 5
32 Degradation kinetics and characterization of degradation pro… (10.5937/arhfarm1902080x)
Abstract
17.47 4
33 Herbal medicines from ginkgo leaf extract in the treatment o… (10.5937/arhfarm2002081p)
Abstract
17.47 4
34 Toxicity of organic and inorganic nickel in pancreatic cell… (10.5937/arhfarm70-29277)
ORCID
17.47 4
35 Oxidative stress and obesity (10.5937/arhfarm72-36123)
ORCID
17.47 4
36 Targeted delivery of anti-inflammatory drugs in lower parts… (10.5937/arhfarm1702124c)
Abstract License
15.05 1
37 Challenges and current views on dosing of radioactive iodine… (10.5937/arhfarm1706333t)
Abstract License
15.05 1
38 Film-forming materials in contemporary formulations of cosme… (10.5937/arhfarm1801046p)
Abstract
15.05 3
39 Dyslipidemia in type 2 diabetes mellitus (10.5937/arhfarm1905338s)
Abstract
15.05 3
40 Botulinum toxin type A: Basic pharmacological profile and th… (10.5937/arhfarm2001010b)
Abstract ORCID
15.05 1
41 Anti-dementia medications: Fighting a losing battle? (10.5937/arhfarm2002055m)
Abstract
15.05 3
42 Testicular dysgenesis syndrome and phthalate exposure: A rev… (10.5937/arhfarm71-34438)
ORCID
15.05 3
43 Treatment-resistant hypertension (10.5937/arhfarm72-34248)
ORCID
15.05 3
44 Thyroid function disorders (10.5937/arhfarm72-39952)
ORCID
15.05 3
45 Green RP-HPLC method for impurity profile of amlodipine in t… (10.5937/arhfarm74-49799)
ORCID
15.05 3
46 Microbiological safety of cosmetic products and potential ri… (10.5937/arhfarm1805949k)
Abstract
11.93 2
47 Molecular biomarkers in multiple sclerosis (10.5937/arhfarm72-36165)
ORCID
11.93 2
48 Investigation of cyclodextrin as potential carrier for lycop… (10.5937/arhfarm74-49440)
ORCID
11.93 2
49 A comprehensive review of the Direct Peptide Reactivity Assa… (10.5937/arhfarm74-49552)
ORCID
11.93 2
50 Molecular modeling and analysis of the 3D pharmacophore stru… (10.5937/arhfarm1804860j)
Abstract
7.53 1